CDC confirms 59 new measles cases, 1,952 total​

CDC confirms 59 new measles cases, 1,952 total​

CDC confirms 59 new measles cases, 1,952 total​

 

Measles rash on boy's chest
CDC / Heinz F. Eichenwald

As the nation moves closer to topping last year’s measles total in just the first half of 2026, the Centers for Disease Control and Prevention (CDC) today confirmed 59 new cases in a nationwide outbreak that has now reached 1,952 infections. 

All but nine cases are locally acquired, with the rest related to international travel. The total for all of last year was 2,288 confirmed cases.

The agency reported two new outbreaks, for a total of 29. Last year the nation saw 48 outbreaks. 

Of this year’s cases, 21% involve children younger than 5 years, and 72% involve kids and young adults up to 19 years. Among all 2026 patients, 92% have been unvaccinated or have an unknown vaccine status. Six percent of patients this year have been hospitalized, compared with 11% last year.

Largest numbers in South Carolina, Utah

According to the CDC measles map, South Carolina has recorded the most cases so far this year, at 669, though its outbreak is now over. Utah is next, with 482 cases—although the Utah health department lists 474, eight more than last week. Parents with students at schools in Heber City in Wasatch County, Utah, are being encouraged to keep unvaccinated children home after two new cases in students.

Texas has 182 cases, and Florida 135, three of them new, according to the CDC map.

Arizona confirmed two new cases, bringing its total to 95. Washington state officials have reported a new case, bringing the state’s total to 45. Pennsylvania has confirmed three new cases in the Susquehanna Valley, and three family members in Atlanta, Georgia, have also tested positive.

In international news, measles deaths in Bangladesh have risen to 499 (11 new), and officials in Mexico have documented four measles deaths in the past month, for a total of 40 in 2025 and 2026.

MRSA under the microscope
NIAID

Global deaths from Staphylococcus aureus–associated lower respiratory tract infections (LRTIs) in older adults nearly tripled from 1990 to 2021, according to a study published yesterday in BMC Infectious Diseases.

Using data from the MICROBE (Multidisciplinary Investigation of Clinical Research Outcomes and Burden Estimates) database, Chinese researchers analyzed estimates on deaths and disability-adjusted life years (DALYs) associated with 22 pathogens and 84 drug-pathogen combinations across 204 countries. They focused specifically on S aureus, including deaths and DALYs attributable to methicillin-resistant S aureus (MRSA). 

S aureus colonizes skin and mucosal surfaces, and the researchers note that older adults are particularly vulnerable to S aureus LRTIs because of the deterioration of the immune system that accompanies aging, the prevalence of comorbidities, and frequent contact with healthcare facilities. MRSA compounds the problem by limiting treatment options.

“The global spread of antimicrobial resistance (AMR) in S. aureus, especially methicillin resistance (MRSA), represents a critical public health issue,” they wrote.

MRSA contributes significantly to mortality

S aureus–associated LRTI deaths in older adults (age 70 and older) rose from 83,363 in 1990 to 250,347 in 2021, and the mortality rate increased from 41.3 per 100,000 to 50.6. DALYs rose from 1.15 million to 3.29 million. MRSA contributed significantly to mortality. Deaths from MRSA LRTIs in older adults rose from 22,481 in 1990 to 75,038 in 2021, and death rates from 11.1 per 100,000 to 15.2 per 100,000. 

In 2021, MRSA mortality among older adults was 6.7 times higher than in adults aged 50 to 69, 9.5-fold higher than in children under 5 years, and more than 70-fold higher than in those aged 5 to 49. DALYs mirrored these trends. The highest mortality burden in 2021 was seen in high-income countries, a finding the study authors attribute in part to rapid demographic aging, while countries in sub-Saharan Africa recorded the highest DALY rate.

“This analysis demonstrates increasing S. aureus LRTIs burden in older adults globally,” the authors concluded. “Our findings underscore the urgent need to prioritize targeted interventions and antimicrobial stewardship to prevent the growing burden of resistant pathogens.”

  • Today, the World Health Organization (WHO) announced that the Netherlands has reported one more case of hantavirus in a crew member who left the MV Hondius cruise ship in Tenerife, Canary Islands, and has been isolating in the Netherlands since then, for a total of 12 cases and three deaths tied to the outbreak. There have been no deaths in 20 days. “The situation is stabilizing,” WHO Director-General Tedros Adhanom Ghebreyesus, PhD, said on X. “WHO is actively monitoring all quarantined passengers and crew alongside national governments. Surveillance will continue until the incubation period ends for everyone who was on board.”
  • This week, the Global Polio Eradication Initiative reported one circulating vaccine-derived poliovirus type 2 (cVDPV2) case each in Nigeria and Yemen and one circulating vaccine-derived poliovirus type 1 (cVDPV1) case in South Sudan. The Nigerian cVDPV2 patient, from Kebbi state, had a paralysis onset of March 17. The country has documented 24 cases so far this year. In Yemen, the cVDPV2 patient, from Abyan governorate, became paralyzed on December 6, 2025. The 2025 total in that country is now 31. The cVDPV1 patient in South Sudan, from Upper Nile state, became paralyzed on March 27, the third such case this year.
  • Jeffery Taubenberger, MD, PhD, acting director of the National Institute for Allergy and Infectious Diseases (NIAID), stepped down from his post two weeks ago, senators revealed yesterday during a Senate Appropriations Committee meeting, leaving another National Institutes of Health (NIH) agency with no leader. A virologist, Taubenberger was appointed acting director in April 2025 after the Trump administration ousted Jeanne Marrazzo, MD, MPH. In the meeting, NIH Director Jay Bhattacharya, MD, PhD, said NIAID needed new leadership because it is shifting away from its focus on civilian biodefense. In a statement today, the Infectious Diseases Society of America and other professional organizations said that such federal leadership departures endanger everyone. 

  

Creator: Center for Infectious Disease Research and Policy (CIDRAP EU)

Related Posts

5 Hidden Water Footprint Habits You Should Stop Today
Hidden Water Footprint
7 Alarming Water Scarcity Global Risk Facts Today
Water Scarcity Global Risk
Biodiversity and Human Health in a Changing World
Biodiversity And Human Health

Most Recent

Spheres of Focus

Infectious Diseases

Climate & Disasters

Food &
Water

Natural
Resources

Built
Environments

Technology & Data

Featured Posts